Strep throat, something we've all had at some point in our lives, is caused by the bacteria Streptococcus pyogenes. Infection ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated ...
Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...
American Academy of Pediatrics clinical practice guideline for well-appearing febrile infants has led to a reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results